Literature DB >> 22823894

Thermally reversible xyloglucan gels as vehicles for nasal drug delivery.

Hitendra S Mahajan1, Vinod Tyagi, Gopal Lohiya, Pankaj Nerkar.   

Abstract

The aim of this study was to investigate the potential application of thermosensitive gels formed by a xyloglucan polysaccharide derived from tamarind seed for nasal drug delivery. Xyloglucan that had been partially degraded by β-galactosidase to eliminate 45% of galactose residues formed gels at concentrations of 2.5% w/w at gelation temperatures decreasing over the range 27-28°C. The in vitro release of ondansetron hydrochloride from the enzyme-degraded xyloglucan gels followed higuchi kinetics over a period of 5 h at 34°C by anomalous transport mechanism. The ex vivo permeation of ondansetron hydrochloride from the gels was sustained. Histological examination of nasal mucosa following a single administration of the gels showed no evidence of mucosal damage. Finally, the bioavailability study in rabbits revealed that the absolute bioavailability of ondansetron hydrochloride was significantly increased from 28.64% in the case of the oral drug solution to 52.79% in the case of the nasal in situ gel. The results of this study suggest the potential of the enzyme-degraded xyloglucan gels as vehicles for nasal delivery of drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22823894     DOI: 10.3109/10717544.2012.704095

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  9 in total

1.  Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery.

Authors:  Yue Sun; Lingjun Li; Huichao Xie; Yuzhen Wang; Shuang Gao; Li Zhang; Fumin Bo; Shanjing Yang; Anjie Feng
Journal:  Int J Nanomedicine       Date:  2020-05-04

Review 2.  Xyloglucan, a Plant Polymer with Barrier Protective Properties over the Mucous Membranes: An Overview.

Authors:  Núria Piqué; María Del Carmen Gómez-Guillén; María Pilar Montero
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

3.  Tamoxifen Citrate Containing Topical Nanoemulgel Prepared by Ultrasonication Technique: Formulation Design and In Vitro Evaluation.

Authors:  Mohammad H Alyami; Hamad S Alyami; Abdullah A Alshehri; Wijdan K Alsharif; Ibrahim Ahmed Shaikh; Thamer S Algahtani
Journal:  Gels       Date:  2022-07-21

Review 4.  Review of Applications and Future Prospects of Stimuli-Responsive Hydrogel Based on Thermo-Responsive Biopolymers in Drug Delivery Systems.

Authors:  Sudipta Chatterjee; Patrick Chi-Leung Hui
Journal:  Polymers (Basel)       Date:  2021-06-24       Impact factor: 4.329

5.  Tamarind Seed Xyloglucans Promote Proliferation and Migration of Human Skin Cells through Internalization via Stimulation of Proproliferative Signal Transduction Pathways.

Authors:  W Nie; A M Deters
Journal:  Dermatol Res Pract       Date:  2013-09-09

6.  Synthesis and biocompatibility of a biodegradable and functionalizable thermo-sensitive hydrogel.

Authors:  Mantosh K Sinha; Jin Gao; Chelsea E T Stowell; Yadong Wang
Journal:  Regen Biomater       Date:  2015-08-20

Review 7.  Biopolymer-based strategies in the design of smart medical devices and artificial organs.

Authors:  Lina Altomare; Lorenzo Bonetti; Chiara E Campiglio; Luigi De Nardo; Lorenza Draghi; Francesca Tana; Silvia Farè
Journal:  Int J Artif Organs       Date:  2018-04-03       Impact factor: 1.595

8.  An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel.

Authors:  Huichao Xie; Lingjun Li; Yue Sun; Yuzhen Wang; Shuang Gao; Yuan Tian; Xuemei Ma; Chengcheng Guo; Fumin Bo; Li Zhang
Journal:  Nanomaterials (Basel)       Date:  2019-01-24       Impact factor: 5.076

9.  Development of a Mucoadhesive in Situ Gelling Formulation for the Delivery of Lactobacillus gasseri into Vaginal Cavity.

Authors:  Barbara Vigani; Angela Faccendini; Silvia Rossi; Giuseppina Sandri; Maria Cristina Bonferoni; Pietro Grisoli; Franca Ferrari
Journal:  Pharmaceutics       Date:  2019-10-03       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.